Imipramine Hydrochloride

盐酸丙米嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameImipramine Hydrochloride
Drug Alias Name盐酸丙咪秦盐酸丙咪嗪丙米嗪盐酸盐JanimineTofranil
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine reuptake inhibitor
TargetsMonoamine transporters
Therapy Area/IndicationsDepressionPain
Global Approved IndicationsDepression
Approved Indications in ChinaDepression
Original Approved Country/TerritoryUnited States
Original Approved Date1959/04/16
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesWright State UniversityShanghai Zhongxi Sunve Pharmaceutical Co Ltd
Inactive CompaniesSanofi-Aventis U.S. LlcGeigy Pharmaceuticals
Active IndicationsDepressionPain
Inactive IndicationsN/A

Other Information

ATC CodeN06AA02
Related LinksWikipediaDrugBankKEGG